Cannabidiol is among the many different substances actively present in the plants marijuana and industrial hemp. Unlike the main psychoactive/mind-altering compound in marijuana, namely tetrahydrocannabinol, cannabidiol does not give users a high. Rather, industry experts claim CBD helps to treat various ailments, including anxiety and chronic pain.
The Food and Drug Administration (FDA) has approved only a single cannabis-derived medication, named Epidiolex, to treat the seizures in severe and rare kinds of epilepsy. Other than that, cannabidiol-based products are yet to get the federal agency’s approval for use in any disease treatment. So in regards to cannabidiol-based products, many ask this question: “Is CBD federally legal?” The answer is yes if the product only contains 0.3% or less tetrahydrocannabinol, and no if it has more THC than that.
Some brands have marketed CBD products with claims that these can treat ailments or provide other therapeutic effects. After that, the government agency responded to such companies with the following statement.
“FDA continues to be concerned at the proliferation of products asserting to contain CBD that are marketed for therapeutic or medical uses although they have not been approved by FDA.”
In spite of no federal approval, you can easily find anecdotes regarding the advantages of cannabidiol for pain. Some individuals credit the substance for helping them reduce migraine, resulting from a car accident. Then there are athletes who said that it helped them deal with pain due to back injuries they picked up when competing. Both groups say that CBD makes pain much more tolerable, rather than eliminating it.
Cannabidiol is mainly derived from industrial hemp, which is a Cannabis sativa plant containing negligence amounts of tetrahydrocannabinol. There are many different approaches to separating cannabidiol from industrial hemp. It is possible to distill the product into a honey-colored and sticky substance, containing small amounts of THC and other cannabis compounds. For those who tend to be tested for tetrahydrocannabinol, we recommend using ‘CBD isolate’ type products. There is virtually no tetrahydrocannabinol in products classified as ‘CBD isolates’, so the consumer can rest assured that they will get a negative drug test result.
Industrial hemp was made legal in 2018. Until then, cannabidiol mainly came from some American states, including Oregon and Colorado, which legalized it before 2018, alongside Asia and Europe. Due to changing regulations, the hemp sector is seeing a remarkable rebirth.